Plunkett Research Online: Compugen Ltd

COMPUGEN LTD (CGEN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Compugen Ltd. is a clinical-stage, therapeutic discovery and development company. The firm utilizes its proprietary computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy. Compugen’s therapeutic pipeline consists of immuno-onc.....



Compugen Ltd
Ticker: CGEN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972 37658585
Fax: 972 37658555
Address: Azrieli Center, 26 Harokmim Street
Building D
Holon, 5885849 Israel

Types Of Business
Industry Ranks

Industry NAICS code:

Drug Discovery
Biotechnology Databases & Diagnostics
Agricultural Biotechnology
Bioinformatics Platform
ContactsDescription
Anat Cohen DayagCEO/President/Director
Ari KrashinCFO/COO
See More
Compugen Ltd. is a clinical-stage, therapeutic discovery and development company. The firm utilizes its proprietary computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy. Compugen’s therapeutic pipeline consists of immuno-onc.....See More See More

Auditor: Kost, Forer, Gabbay & Kasierer
Legal Advisor: Meitar Liquornik Geva & Leshem Brandwein
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
COM701
BAY 1905254
COM902
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: